Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year
Lantheus announced that an image generated using its investigational agent LNTH-2513 (18F-GP1) was awarded SNMMI’s Image of the Year at the 2026 Annual Meeting. The award recognizes investigator-initiated trial results evaluating LNTH-2513 PET/CT for detecting acute lower-extremity deep vein thrombosis (DVT) in 46 symptomatic patients. The study demonstrated high diagnostic accuracy for proximal DVT, with 95% sensitivity and 92% specificity, and identified concomitant pulmonary embolism in 22 of the 46 patients. Lead investigator Dr.
Key figures
- Drug Name
- LNTH-2513 (18F-GP1)
- Phase Of Trial
- investigator-initiated open-label, non-randomized
- Patient count
- 46
- Sensitivity proximal dvt
- 95%
- Specificity proximal dvt
- 92%
- Pulmonary embolism detected
- 22
- Negative percent agreement distal dvt
- 90%
- Positive percent agreement distal dvt
- 96%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.